Search

everythinglearnresearchcommunity

for

Search:↓

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

AQB reduces harmful skin changes in systemic sclerosis.

Baricitinib effectively regrows hair in severe alopecia areata cases.

JAK inhibitors are effective for long-term management of alopecia areata.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Pulsed Dye Laser effectively treats skin lesions in Rosai–Dorfman Disease.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Targeting the AhR pathway may help treat alopecia areata.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

The lemur's testicular tumor was removed, improving its coat and behavior, with no signs of cancer spread.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

B cells can both help and hinder the body's defense against melanoma.